Paper32207688
2019 Expert opinion on biological treatment use in inflammatory bowel disease management.
Törüner M and 8 others. Turk J Gastroenterol, 2019. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. 2019 Expert opinion on biological treatment use in inflammatory bowel disease management. Papers, record 32207688. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32207688
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 2019 Expert opinion on biological treatment use in inflammatory bowel disease management.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Products | Major topic |
| Colitis, Ulcerative | Major topic |
| Crohn Disease | Major topic |
| Gastrointestinal Agents | Major topic |
| Inflammatory Bowel Diseases | Major topic |
| Disease Management | |
| Humans | |
| Practice Guidelines as Topic |
Source PubMed
References213
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21407188 | Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. | Am J Gastroenterol | 2011 | https://conductscience.org/library/papers/21407188 | PubMed |
| 2 | 24641622 | Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis. | Aliment Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24641622 | PubMed |
| 3 | 9510317 | Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis. | Dis Colon Rectum | 1998 | https://conductscience.org/library/papers/9510317 | PubMed |
| 4 | 18727929 | Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial. | Gastroenterology | 2008 | https://conductscience.org/library/papers/18727929 | PubMed |
| 5 | 19821389 | Interventions for prevention of post-operative recurrence of Crohn's disease. | Cochrane Database Syst Rev | 2009 | https://conductscience.org/library/papers/19821389 | PubMed |
| 6 | 22890223 | Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry. | Am J Gastroenterol | 2012 | https://conductscience.org/library/papers/22890223 | PubMed |
| 7 | 30543573 | Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab. | Eur J Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/30543573 | PubMed |
| 8 | 21122553 | European evidenced-based consensus on reproduction in inflammatory bowel disease. | J Crohns Colitis | 2010 | https://conductscience.org/library/papers/21122553 | PubMed |
| 9 | 18242053 | Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. | Reprod Toxicol | 2008 | https://conductscience.org/library/papers/18242053 | PubMed |
| 10 | 27579102 | Is breastfeeding safe with azathioprine? | Obstet Med | 2011 | https://conductscience.org/library/papers/27579102 | PubMed |
| 11 | 21209123 | Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial. | Gut | 2011 | https://conductscience.org/library/papers/21209123 | PubMed |
| 12 | 29682686 | Resolution of Metastatic Colon Cancer upon Withdrawal of Anti-TNF Therapy for Crohn's Disease. | J Gastrointest Cancer | 2019 | https://conductscience.org/library/papers/29682686 | PubMed |
| 13 | 16678077 | Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. | Clin Gastroenterol Hepatol | 2006 | https://conductscience.org/library/papers/16678077 | PubMed |
| 14 | 28158411 | The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease. | J Crohns Colitis | 2017 | https://conductscience.org/library/papers/28158411 | PubMed |
| 15 | 23897285 | IBD medications during pregnancy and lactation. | Nat Rev Gastroenterol Hepatol | 2014 | https://conductscience.org/library/papers/23897285 | PubMed |
| 16 | 22062358 | Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. | Gastroenterology | 2012 | https://conductscience.org/library/papers/22062358 | PubMed |
| 17 | 22530631 | Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease. | Aliment Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22530631 | PubMed |
| 18 | 7797011 | Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). | Gastroenterology | 1995 | https://conductscience.org/library/papers/7797011 | PubMed |
| 19 | 29317275 | Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease. | Gastroenterology | 2018 | https://conductscience.org/library/papers/29317275 | PubMed |
| 20 | 20055530 | Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development. | BioDrugs | 2010 | https://conductscience.org/library/papers/20055530 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35726844 | Perception of COVID-19 Pandemic Among IBD Clinicians and IBD Surgeons in Black Sea Region: A Cross-Sectional Questionnaire Study. | Turk J Gastroenterol | 2022 | https://conductscience.org/library/papers/35726844 | PubMed |
| 34405814 | Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic. | Turk J Gastroenterol | 2021 | https://conductscience.org/library/papers/34405814 | PubMed |
| 32774388 | Secukinumab-Induced Inflammatory Bowel Disease in a Patient Treated for Chronic Plaque Psoriasis and Psoriatic Arthritis: A Case Report and Review of the Role of Novel Biologic Agents Targeting the p19 Subunit of IL-23. | Case Rep Med | 2020 | https://conductscience.org/library/papers/32774388 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32207688
GET https://conductscience.org/api/papers/v1/32207688/references?page=2